Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with a clinical trial specifically designed for the genetic signature of their disease.
What’s Next?— Predictions for What Happens After MDMA is Approved | Psychedelic Invest
The entire psychedelic industry is holding its breath in anticipation of the long-awaited FDA approval of MDMA. It will certainly be a big step for
June 22, 2023